Mitchell Evers
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- Phagocytosis and Immune Regulation
- Immunotherapy and Immune Responses
-
- Monoclonal and Polyclonal Antibodies Research
Papers in ⓘ
-
- Monoclonal and Polyclonal Antibodies Research 9
-
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 4
- Immunotherapy and Immune Responses 2
- Co-authors
- Jeanette H.W. Leusen (13 shared papers)Thomas Valerius (8 shared papers)J.H. Marco Jansen (7 shared papers)Toine ten Broeke (4 shared papers)Maaike Nederend (6 shared papers)Thies Rösner (4 shared papers)Arianne M. Brandsma (1 shared paper)Geert van Tetering (2 shared papers)
- Journals
- mAbs (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Molecular Cancer Therapeutics (1 paper)British Journal of Haematology (1 paper)Cells (1 paper)
- Partner nations
- NetherlandsGermanyNorway
In The Last Decade
Mitchell Evers
12 papers receiving 339 citations
Peers
Comparison fields: 5 of 48
- Immunology 222
- Radiology, Nuclear Medicine and Imaging 152
- Oncology 89
- Genetics 33
- Immunology and Allergy 15
Countries citing papers authored by Mitchell Evers
This map shows the geographic impact of Mitchell Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Evers more than expected).
Fields of papers citing papers by Mitchell Evers
This network shows the impact of papers produced by Mitchell Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Evers. The network helps show where Mitchell Evers may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell Evers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 109 | |
| 2 | 2018 | 48 | |
| 3 | 2020 | 45 | |
| 4 | 2021 | 34 | |
| 5 | 2018 | 25 | |
| 6 | 2021 | 21 | |
| 7 | 2020 | 17 | |
| 8 | 2023 | 16 | |
| 9 | 2021 | 11 | |
| 10 | 2023 | 8 | |
| 11 | 2018 | 7 | |
| 12 | 2025 | 3 | |
| 13 | 2025 | 0 |
About Mitchell Evers
Mitchell Evers is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 13 papers that have together received 344 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers), Glycosylation and Glycoproteins Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Blood groups and transfusion (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Immunology (222 citations), Radiology, Nuclear Medicine and Imaging (152 citations), Oncology (89 citations), Genetics (33 citations) and Immunology and Allergy (15 citations). Mitchell Evers has collaborated with scholars based in Netherlands, Germany and Norway. Frequent co-authors include Jeanette H.W. Leusen, Thomas Valerius, J.H. Marco Jansen, Toine ten Broeke, Maaike Nederend, Thies Rösner, Arianne M. Brandsma, Geert van Tetering, Saskia Meyer and Inger Sandlie. Their work appears in journals such as mAbs, Journal for ImmunoTherapy of Cancer, Molecular Cancer Therapeutics, British Journal of Haematology and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.